Brixner D - Search Results

1

Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis.

Rochau U, Kluibenschaedl M, Stenehjem D, Kuan-Ling K, Radich J, Oderda G, Brixner D, Siebert U. Rochau U, et al. Among authors: brixner d. Leuk Res Treatment. 2015;2015:982395. doi: 10.1155/2015/982395. Epub 2015 Dec 10. Leuk Res Treatment. 2015. PMID: 26783469 Free PMC article.

2

Has the cost-effectiveness of Xolair (omalizumab) been underestimated?

Asche CV, Brixner DI, Oderda GM. Asche CV, et al. J Allergy Clin Immunol. 2005 May;115(5):1095; author reply 1095-6. doi: 10.1016/j.jaci.2004.12.1136. J Allergy Clin Immunol. 2005. PMID: 15867875 No abstract available.

3

The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.

Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, Joshua-Gotlib S, Brixner DI. Joish VN, et al. Curr Med Res Opin. 2005 Apr;21(4):535-44. doi: 10.1185/030079905X38240. Curr Med Res Opin. 2005. PMID: 15899102

4

Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices.

Brixner DI, Oderda GM, Nickman NA, Beveridge R, Jorgenson JA. Brixner DI, et al. J Natl Compr Canc Netw. 2006 Mar;4(3):197-208. doi: 10.6004/jnccn.2006.0020. J Natl Compr Canc Netw. 2006. PMID: 16507268

5

Naturalistic impact of second-generation antipsychotics on weight gain.

Brixner DI, Said Q, Corey-Lisle PK, Tuomari AV, L'italien GJ, Stockdale W, Oderda GM. Brixner DI, et al. Ann Pharmacother. 2006 Apr;40(4):626-32. doi: 10.1345/aph.1G564. Epub 2006 Mar 28. Ann Pharmacother. 2006. PMID: 16569802

6

Opioid expenditures and utilization in the Medicaid system.

Brixner DI, Oderda GM, Roland CL, Rublee DA. Brixner DI, et al. J Pain Palliat Care Pharmacother. 2006;20(1):5-13. J Pain Palliat Care Pharmacother. 2006. PMID: 16687350

7

Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin.

LaFleur J, Thompson CJ, Joish VN, Charland SL, Oderda GM, Brixner DI. LaFleur J, et al. Ann Pharmacother. 2006 Jul-Aug;40(7-8):1274-9. doi: 10.1345/aph.1G646. Epub 2006 Jul 18. Ann Pharmacother. 2006. PMID: 16849622

8

Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.

Biskupiak JE, Brixner DI, Howard K, Oderda GM. Biskupiak JE, et al. J Pain Palliat Care Pharmacother. 2006;20(3):7-14. J Pain Palliat Care Pharmacother. 2006. PMID: 16931473

9

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.

Creekmore FM, Oderda GM, Pendleton RC, Brixner DI. Creekmore FM, et al. Pharmacotherapy. 2006 Oct;26(10):1438-45. doi: 10.1592/phco.26.10.1438. Pharmacotherapy. 2006. PMID: 16999654

10

It is important to distinguish CER from patient-centered outcomes research. Introduction.

Brixner DI, Oderda G. Brixner DI, et al. J Manag Care Pharm. 2012 May;18(4 Suppl A):S3-4. doi: 10.18553/jmcp.2012.18.S8-A.S03. J Manag Care Pharm. 2012. PMID: 22578209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters